Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease
about
Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's DiseaseCorrelations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/1 mouse model of Huntington's diseaseNigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synucleinBrain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.Evolution of structural abnormalities in the rat brain following in utero exposure to maternal immune activation: A longitudinal in vivo MRI study.Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease.Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke.Huntington's disease mouse models online: high-resolution MRI images with stereotaxic templates for computational neuroanatomyAn animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors.Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington's Disease.Characterization of the resting-state brain network topology in the 6-hydroxydopamine rat model of Parkinson's disease.Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproateRegistration of challenging pre-clinical brain imagesA comparison of automated anatomical-behavioural mapping methods in a rodent model of strokeSimultaneous effects on parvalbumin-positive interneuron and dopaminergic system development in a transgenic rat model for sporadic schizophrenia.Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.The Proteasome Inhibition Model of Parkinson's Disease.The Cellular Diversity of the Pedunculopontine Nucleus: Relevance to Behavior in Health and Aspects of Parkinson's Disease.Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson's disease.[18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease.
P2860
Q27316725-149DA6C2-7128-4D74-8D2B-EADB8693829CQ27334759-FFE4F5B7-C98F-4D99-B43B-F9E2DC176992Q30633819-AAC6F806-EAF2-4386-9570-9D77F67F92E7Q30833645-8D3B91DA-6C50-4982-806D-26EE5D80E1AEQ33718930-D9C958A9-DC8F-40D1-823C-8C9B9BE77588Q34085167-6E54BCAE-2FE1-4D85-9DC6-3F4D5631E575Q34115945-1E2CD827-D709-4B56-9018-31C22AC83581Q34541881-79DCB995-477B-45F8-8C1E-87CD80C50CEEQ35057159-2C217450-9641-4D4F-A260-2E319EBCB11FQ35978159-A763C7E3-20C6-47C3-9B0E-408E4C43B15EQ36252810-34EB4BD2-CD1D-4500-BD93-7124EE82076AQ36294008-FC912B9E-95EC-4C7E-A80F-01F3E515F859Q36587423-05F92FB1-609B-46DC-B58E-AD6919E6BBD8Q36930569-6BE7F3D0-5D35-4A2D-800F-16EF1C2DB027Q37138990-31296E54-4886-4763-BDDE-BB51909CAE0BQ37323826-B4C741F9-2B7C-41FE-92FA-F44CDA6F8171Q37880260-B1B81AEE-A7DA-40BE-B5AC-BC787BE198A3Q37918059-1EDAAEC8-D6DD-4AF5-8CCC-104BC8ECC52BQ38821744-C54C5843-3D09-4970-BF98-F851A00D2DA9Q38996038-3EA176F0-CA05-4AD9-9D79-360D6AE5B9C5Q39033679-E1210000-94EC-46DD-B372-45A03B716945Q39443289-40A680BD-529B-40BE-8BDE-D37E0AA959CBQ41105821-B2B69374-4518-4EE9-A46C-A59EDE1360D2Q48220692-4C8C4936-D1DD-43A9-A835-68831225054C
P2860
Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evolution of extra-nigral dama ...... r model of Parkinson's disease
@ast
Evolution of extra-nigral dama ...... r model of Parkinson's disease
@en
Evolution of extra-nigral dama ...... r model of Parkinson's disease
@nl
type
label
Evolution of extra-nigral dama ...... r model of Parkinson's disease
@ast
Evolution of extra-nigral dama ...... r model of Parkinson's disease
@en
Evolution of extra-nigral dama ...... r model of Parkinson's disease
@nl
prefLabel
Evolution of extra-nigral dama ...... r model of Parkinson's disease
@ast
Evolution of extra-nigral dama ...... r model of Parkinson's disease
@en
Evolution of extra-nigral dama ...... r model of Parkinson's disease
@nl
P2093
P2860
P3181
P1433
P1476
Evolution of extra-nigral dama ...... r model of Parkinson's disease
@en
P2093
Anthony C Vernon
Saga M Johansson
William R Crum
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0017269
P407
P50
P577
2011-01-01T00:00:00Z